Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1796-1807
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1796
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1796
Diagnostic variable | AUC | 95%CI | Cut-off | Sensitivity | Specificity | Youden index |
T stage | ||||||
CA19-9 | 0.773 | 0.684-0.863 | 23.63 | 53.23% | 100.00% | 53.23% |
CA125 | 0.802 | 0.716-0.888 | 66.90 | 67.74% | 90.48% | 58.22% |
DCE-MRI parameters + tumor markers | 0.836 | 0.756-0.916 | 0.93 | 72.58% | 95.24% | 67.82% |
Differentiation degree | ||||||
CA19-9 | 0.834 | 0.758-0.909 | 27.49 | 81.82% | 68.42% | 50.24% |
CA125 | 0.796 | 0.711-0.881 | 66.82 | 62.12% | 89.47% | 51.60% |
DCE-MRI parameters + tumor markers | 0.946 | 0.903-0.990 | 0.76 | 87.88% | 97.37% | 85.25% |
- Citation: Mu RQ, Lv JW, Ma CY, Ma XH, Xing D, Ma HS. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis. World J Gastrointest Oncol 2024; 16(5): 1796-1807
- URL: https://www.wjgnet.com/1948-5204/full/v16/i5/1796.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i5.1796